These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7929727)

  • 1. Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity.
    Shrivastav P; Nadkarni P; Craft I
    Hum Reprod; 1994 May; 9(5):812-4. PubMed ID: 7929727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis.
    Grochowski D; Sola E; Kulikowski M; Kuczyński W; Wołczyński S; Szamatowicz M
    J Assist Reprod Genet; 1995 Jul; 12(6):394-6. PubMed ID: 8589562
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy after ovulation induction: a case report.
    Yang F; Hu H; He PZ; Zhang M; Qian Y; Li Y
    Clin Exp Obstet Gynecol; 2017; 44(2):292-295. PubMed ID: 29746043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome.
    Chan CC; Yin CS; Lan SC; Chen IC; Wu GJ
    J Chin Med Assoc; 2004 Apr; 67(4):197-9. PubMed ID: 15244020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for recovery time in patients suffering from severe OHSS.
    Nouri K; Tempfer CB; Lenart C; Windischbauer L; Walch K; Promberger R; Ott J
    Reprod Biol Endocrinol; 2014 Jul; 12():59. PubMed ID: 24996451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines.
    Gebril A; Hamoda H; Mathur R
    Hum Fertil (Camb); 2018 Jun; 21(2):98-105. PubMed ID: 28554223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].
    Moosová M; Moos J; Filová V; Pavelková J; Jarosová R; Rezábek K
    Ceska Gynekol; 2011 Apr; 76(2):123-7. PubMed ID: 21649996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy.
    Aboulghar MA; Mansour RT; Serour GI; Sattar MA; Amin YM; Elattar I
    Obstet Gynecol; 1993 Jan; 81(1):108-11. PubMed ID: 8416442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory evaluation of hospitalized patients with severe ovarian hyperstimulation syndrome.
    Cunha-Filho JS; Samama M; Fanchin R; Righini C; Kadoch IJ; Frydman R; Olivennes F
    Reprod Biomed Online; 2003 Jun; 6(4):448-51. PubMed ID: 12831592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ovarian hyperstimulation syndrome.
    Aboulghar M
    Semin Reprod Med; 2010 Nov; 28(6):532-9. PubMed ID: 21082512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S188-93. PubMed ID: 19007627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome.
    Ling SY; Chong KM; Hwang JL
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):70-2. PubMed ID: 17272214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin].
    Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A
    Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid].
    Kably Ambe A; Ruiz Anguas J; Sánchez de León A
    Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and management of ovarian hyperstimulation syndrome.
    Shmorgun D; Claman P;
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1156-1162. PubMed ID: 22082791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.
    Csokmay JM; Yauger BJ; Henne MB; Armstrong AY; Queenan JT; Segars JH
    Fertil Steril; 2010 Jan; 93(1):167-73. PubMed ID: 18990389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome.
    Zalel Y; Orvieto R; Ben-Rafael Z; Homburg R; Fisher O; Insler V
    Gynecol Endocrinol; 1995 Dec; 9(4):313-5. PubMed ID: 8629460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.